0000920465-19-000051.txt : 20190313
0000920465-19-000051.hdr.sgml : 20190313
20190313205452
ACCESSION NUMBER: 0000920465-19-000051
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190313
DATE AS OF CHANGE: 20190313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wellinghoff Darryl
CENTRAL INDEX KEY: 0001770350
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19679582
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
wf-form3_155252487518774.xml
FORM 3
X0206
3
2019-03-05
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001770350
Wellinghoff Darryl
C/O LA JOLLA PHARMACEUTICAL COMPANY
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
7.0
2029-03-05
Common Stock
80000.0
D
The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
/s/ Ryan Murr, as attorney-in-fact for Darryl Wellinghoff
2019-03-13